“…Current state-of-the-art and frequently used automated segmentation methods suffer from substantial limitations with respect to both reproducibility and accuracy, which is partly due to the presence of MS pathological changes. ( Popescu et al, 2014 , Popescu et al, 2016 , Gelineau-Morel et al, 2012 , Meijerman et al, 2018 , Amiri et al, 2018 , de Sitter et al, 2020 ) Specifically, there are various confounds that can affect the measurement of dGM atrophy: image registration and segmentation can be negatively affected by the presence of white matter lesions, ( Gelineau-Morel et al, 2012 , de Sitter et al, 2020 ) generalized or local atrophy, or subtle tissue contrast changes ( Amiri et al, 2018 , Westlye et al, 2009 ). To achieve accurate automated dGM segmentation in the presence of MS abnormalities, it is important that new methods are validated against expert reference outlines of dGM in representative MS samples.…”